Form 4: Alignment Healthcare President Sells 30,000 Shares Under 10b5-1 Plan

Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock at a weighted average price of $13.6128 per share on January 15, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Dawn Christine Maroney, President of Alignment Healthcare, executed a sale of 30,000 common stock shares on January 15, 2025.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2024.
• The shares were sold at a weighted average price of $13.6128 per share.
• The sale price ranged from $13.40 to $13.91 per share.
• Following the transaction, Ms. Maroney directly owns 1,606,097 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive under a pre-arranged plan. It does not suggest any positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for executives who have pre-arranged trading plans. It does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies, especially under pre-arranged 10b5-1 plans.
• The volume of shares sold is not unusual for an executive of Ms. Maroney's position.
• Comparable companies often see similar filings from their executives.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment, but is unlikely to have a significant effect due to the pre-arranged nature of the transaction.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Sale, Rule 10b5-1, Alignment Healthcare, ALHC, Dawn Christine Maroney